Fri Sep 13 00:35:52 UTC 2024: ## Sydney Startup Develops Headband for ADHD Treatment, Raising $5.3 Million
**Sydney, Australia** – Neurode, a Sydney-based startup, has secured $5.3 million in funding for its innovative headband designed to assist people with ADHD. The headband utilizes non-invasive brain stimulation as an alternative to traditional ADHD medication, offering a potential solution for the millions struggling with the condition.
Co-founded by neuroscientist Nathalie Gouailhardou, who has lived with ADHD since childhood, and electrical engineer Damian Sofrevski, Neurode combines brain monitoring and stimulation technologies into a user-friendly home device. The headband, worn for just 20 minutes daily, targets the prefrontal cortex, the area of the brain responsible for focus and executive function, using mild electrical stimulation to balance brain activity.
“Neurode was born from my personal struggle to find effective treatment without debilitating side effects,” shared Gouailhardou, highlighting the limitations of traditional medications like Ritalin and Adderall for many individuals. “Our breakthrough lies in making brain imaging technology affordable and portable, delivering non-invasive brain stimulation without compromising data quality.”
The headband also tracks brain activity using light-based sensors, allowing users to monitor their progress over time. Personalized treatment plans and unique brain monitoring data provide a tailored approach to managing ADHD.
As ADHD diagnoses increase, especially among adults, Neurode aims to address the growing demand for alternative treatment options. “We’re receiving thousands of messages from people who have experienced intolerable side effects from medication and are seeking a better solution,” stated Gouailhardou.
The recent funding will be used to refine the headband, complete clinical trials, and launch a private beta program for user feedback. The company also envisions future applications for its technology, including cognitive decline and depression monitoring.
Neurode’s innovative approach to ADHD treatment offers a promising alternative for those seeking a medication-free option. The company’s mission is to empower individuals to take control of their ADHD and achieve their full potential.
First Piper 